Davide Romeres1, Karen Olson2, Rickey Carter3, Claudio Cobelli1, Chiara Dalla Man1, Ananda Basu4, Rita Basu4. 1. Department of Information Engineering, University of Padova, Padova, Italy. 2. Division of Endocrinology, Center of Diabetes Technology, University of Virginia School of Medicine, Charlottesville, VA. 3. Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL. 4. Division of Endocrinology, Center of Diabetes Technology, University of Virginia School of Medicine, Charlottesville, VA basu.rita@virginia.edu.
Abstract
OBJECTIVE: To distinguish the effects of hyperglycemia and hyperinsulinemia on exercise-induced increases in Rd and endogenous glucose production (EGP) in type 1 diabetes. RESEARCH DESIGN AND METHODS: We studied six participants without diabetes and six participants with type 1 diabetes on three visits in random order for the following: euglycemia, low insulin (EuLoI); euglycemia, high insulin (EuHiI); and hyperglycemia, low insulin (HyLoI). Glucose fluxes were measured using [6,6-2H2] glucose before, during, and after 60 min of exercise. RESULTS: Rd increased (P < 0.01) with exercise within groups, while peak Rd during exercise was lower (P < 0.01) in participants with type 1 diabetes than participants without diabetes during all visits. In type 1 diabetes participants, EGP increased (P < 0.001) with exercise during EuLoI and HyLoI but not during EuHiI. This demonstrates that hyperinsulinemia, but not hyperglycemia, blunts the compensatory exercise-induced increase in EGP in type 1 diabetes. CONCLUSIONS: The data from this pilot study indicate that 1) exercise-induced compensatory increase in EGP was inhibited in participants with type 1 diabetes with hyperinsulinemia but not with hyperglycemia; 2) in contrast, in participants without diabetes, exercise-induced increase in EGP was inhibited only during combined hyperinsulinemia and hyperglycemia. Taken together, these results suggest that low insulin coupled with euglycemia or modest hyperglycemia appear to be the most favorable milieu for type 1 diabetes during exercise.
RCT Entities:
OBJECTIVE: To distinguish the effects of hyperglycemia and hyperinsulinemia on exercise-induced increases in Rd and endogenous glucose production (EGP) in type 1 diabetes. RESEARCH DESIGN AND METHODS: We studied six participants without diabetes and six participants with type 1 diabetes on three visits in random order for the following: euglycemia, low insulin (EuLoI); euglycemia, high insulin (EuHiI); and hyperglycemia, low insulin (HyLoI). Glucose fluxes were measured using [6,6-2H2] glucose before, during, and after 60 min of exercise. RESULTS: Rd increased (P < 0.01) with exercise within groups, while peak Rd during exercise was lower (P < 0.01) in participants with type 1 diabetes than participants without diabetes during all visits. In type 1 diabetesparticipants, EGP increased (P < 0.001) with exercise during EuLoI and HyLoI but not during EuHiI. This demonstrates that hyperinsulinemia, but not hyperglycemia, blunts the compensatory exercise-induced increase in EGP in type 1 diabetes. CONCLUSIONS: The data from this pilot study indicate that 1) exercise-induced compensatory increase in EGP was inhibited in participants with type 1 diabetes with hyperinsulinemia but not with hyperglycemia; 2) in contrast, in participants without diabetes, exercise-induced increase in EGP was inhibited only during combined hyperinsulinemia and hyperglycemia. Taken together, these results suggest that low insulin coupled with euglycemia or modest hyperglycemia appear to be the most favorable milieu for type 1 diabetes during exercise.
Authors: Sybil A McAuley; Jodie C Horsburgh; Glenn M Ward; André La Gerche; Judith L Gooley; Alicia J Jenkins; Richard J MacIsaac; David N O'Neal Journal: Diabetologia Date: 2016-05-11 Impact factor: 10.122
Authors: Vinutha B Shetty; Paul A Fournier; Raymond J Davey; Adam J Retterath; Nirubasini Paramalingam; Heather C Roby; Matthew N Cooper; Elizabeth A Davis; Timothy W Jones Journal: J Clin Endocrinol Metab Date: 2016-01-14 Impact factor: 5.958
Authors: Karen M Rothacker; Sam Armstrong; Grant J Smith; Nat Benjanuvatra; Brendan Lay; Peter Adolfsson; Timothy W Jones; Paul A Fournier; Elizabeth A Davis Journal: Diabetologia Date: 2021-05-04 Impact factor: 10.122